Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 1
1950 1
1951 4
1952 3
1953 9
1954 8
1955 10
1956 5
1957 4
1958 6
1959 3
1960 2
1961 4
1963 12
1964 12
1965 3
1966 3
1967 3
1968 11
1969 3
1970 8
1971 10
1972 6
1973 1
1974 9
1975 19
1976 12
1977 13
1978 7
1979 10
1980 10
1981 14
1982 11
1983 15
1984 12
1985 33
1986 19
1987 27
1988 34
1989 37
1990 41
1991 31
1992 54
1993 48
1994 56
1995 50
1996 36
1997 28
1998 40
1999 33
2000 35
2001 48
2002 52
2003 48
2004 63
2005 50
2006 38
2007 34
2008 39
2009 33
2010 39
2011 39
2012 33
2013 47
2014 69
2015 75
2016 83
2017 48
2018 64
2019 64
2020 55
2021 79
2022 40
2023 68
2024 65
2025 28

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,036 results

Results by year

Filters applied: . Clear all
Page 1
Langerhans cells and skin immune diseases.
Zhu R, Yao X, Li W. Zhu R, et al. Eur J Immunol. 2024 Oct;54(10):e2250280. doi: 10.1002/eji.202250280. Epub 2024 Jul 18. Eur J Immunol. 2024. PMID: 39030782 Review.
Langerhans cells (LCs) are the key antigen-presenting cells in the epidermis in normal conditions and respond differentially to environmental and/or endogenous stimuli, exerting either proinflammatory or anti-inflammatory effects. ...
Langerhans cells (LCs) are the key antigen-presenting cells in the epidermis in normal conditions and respond differentially to envir …
Langerhans cell histiocytosis: promises and caveats of targeted therapies in high-risk and CNS disease.
Abla O. Abla O. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):386-395. doi: 10.1182/hematology.2023000439. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066856 Free PMC article. Review.
Langerhans cell histiocytosis (LCH) is a rare myeloid neoplasm driven by activating mutations in the MAPK pathway, most commonly BRAF-V600E and MAP2K1. ...Lastly, emerging strategies, such as the new panRAF inhibitor (Day 101) in patients with R/R LCH, ERK1/2 …
Langerhans cell histiocytosis (LCH) is a rare myeloid neoplasm driven by activating mutations in the MAPK pathway, most commonly BRAF …
Endocannabinoids in the Islets of Langerhans: the ugly, the bad, and the good facts.
González-Mariscal I, Egan JM. González-Mariscal I, et al. Am J Physiol Endocrinol Metab. 2018 Aug 1;315(2):E174-E179. doi: 10.1152/ajpendo.00338.2017. Epub 2018 Apr 6. Am J Physiol Endocrinol Metab. 2018. PMID: 29631361 Free PMC article. Review.
There is an autonomous ECS in the endocrine pancreas, including the cannabinoid 1 receptor (CB(1)R) that is present in beta-cells. Here, we discuss conflicts that have arisen with regard to the function(s) of the ECs in the endocrine pancreas and that have caused confusion …
There is an autonomous ECS in the endocrine pancreas, including the cannabinoid 1 receptor (CB(1)R) that is present in beta-cells. He …
An Autonomous Cannabinoid System in Islets of Langerhans.
Aseer KR, Egan JM. Aseer KR, et al. Front Endocrinol (Lausanne). 2021 Jul 5;12:699661. doi: 10.3389/fendo.2021.699661. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34290671 Free PMC article. Review.
While endocannabinoids (ECs) and cannabis were primarily studied for their nervous system effects, it is now clear that ECs are also produced in the periphery where they regulate several physiological processes, including energy storage, glucose and lipid metabolism, insulin secr …
While endocannabinoids (ECs) and cannabis were primarily studied for their nervous system effects, it is now clear that ECs are also produce …
Histiocytosis.
Vashisht D, Muralidharan CG, Sivasubramanian R, Gupta DK, Bharadwaj R, Sengupta P. Vashisht D, et al. Med J Armed Forces India. 2015 Apr;71(2):197-200. doi: 10.1016/j.mjafi.2012.09.004. Epub 2012 Nov 29. Med J Armed Forces India. 2015. PMID: 25859088 Free PMC article. No abstract available.
Corneal Langerhans cells in children with celiac disease.
Gad H, Mohammed I, Saraswathi S, Al-Jarrah B, Ferdousi M, Petropoulos IN, Ponirakis G, Khan A, Singh P, Al Khodor S, Elawad M, Almasri W, Abdelrahman H, Hussain K, Hendaus MA, Al-Mudahka F, Abouhazima K, Akobeng AK, Malik RA. Gad H, et al. Sci Rep. 2022 Oct 31;12(1):18289. doi: 10.1038/s41598-022-22376-w. Sci Rep. 2022. PMID: 36316419 Free PMC article.
The total (33.33(16.67-59.37) vs. 51.56(30.21-85.42); P = 0.343), immature (33.33(16.67-52.08) vs. 44.79(29.17-82.29); P = 0.752) and mature (1.56(0-5) vs. 1.56(1.04-8.33); P = 0.752) LC density did not differ between the CeD and control groups. However, immature (r = 0.53 …
The total (33.33(16.67-59.37) vs. 51.56(30.21-85.42); P = 0.343), immature (33.33(16.67-52.08) vs. 44.79(29.17-82.29); P = 0.752) and mature …
Cutaneous dendritic cells.
Valladeau J, Saeland S. Valladeau J, et al. Semin Immunol. 2005 Aug;17(4):273-83. doi: 10.1016/j.smim.2005.05.009. Semin Immunol. 2005. PMID: 15953735 Review.
Cutaneous dendritic cells (DC) include epidermal Langerhans cells (LC), interstitial/dermal dendritic cells (DDC), as well as plasmacytoid DC (pDC) that occur under pathological conditions. ...
Cutaneous dendritic cells (DC) include epidermal Langerhans cells (LC), interstitial/dermal dendritic cells (DDC), as well as plasmac …
The Non-Langerhans Cell Histiocytoses (Rare Histiocytoses) - Clinical Aspects and Therapeutic Approaches.
Classen CF, Minkov M, Lehrnbecher T. Classen CF, et al. Klin Padiatr. 2016 Nov;228(6-07):294-306. doi: 10.1055/s-0042-109713. Epub 2016 Nov 15. Klin Padiatr. 2016. PMID: 27846659 Review. English.
Rare histiocytoses, also called non-Langerhans cell histiocytoses, include all proliferative disorders of histiocytes, macrophages and dendritic cells that are not classified as Langerhans cell histiocytosis (LCH) and do not belong to the hemophagocytic lymphohistio …
Rare histiocytoses, also called non-Langerhans cell histiocytoses, include all proliferative disorders of histiocytes, macrophages an …
Clinical features and treatment outcomes of liver involvement in paediatric Langerhans cell histiocytosis.
Ge X, Ou W, Wei A, Lian H, Ma H, Cui L, Wang D, Zhang L, Wang X, He L, Zhang R, Wang T. Ge X, et al. BMC Pediatr. 2024 May 7;24(1):316. doi: 10.1186/s12887-024-04764-5. BMC Pediatr. 2024. PMID: 38714959 Free PMC article.
Langerhans cell histiocytosis (LCH) is the most common histiocytic disorder in children, and liver involvement in LCH is rare. ...
Langerhans cell histiocytosis (LCH) is the most common histiocytic disorder in children, and liver involvement in LCH is rare. ...
Neuroimaging manifestations of paediatric histiocytoses.
Tan HEI, Lakshmanan R, Warne R, Walwyn T, Roebuck D. Tan HEI, et al. J Med Imaging Radiat Oncol. 2023 Nov 14. doi: 10.1111/1754-9485.13602. Online ahead of print. J Med Imaging Radiat Oncol. 2023. PMID: 37964685
Classified into five groups in 2016, including Langerhans-related (L), cutaneous (C), malignant (M), Rosai-Dorfman disease (R) and haemophagocytic lymphohistiocytosis (H), newer entities such as ALK-positive histiocytosis have also emerged, heralding the era of mole …
Classified into five groups in 2016, including Langerhans-related (L), cutaneous (C), malignant (M), Rosai-Dorfman disease (R) …
2,036 results